32 related articles for article (PubMed ID: 37982184)
1. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
[TBL] [Abstract][Full Text] [Related]
2. Interaction between Permeation Enhancers and Lipid Bilayers.
Kang C; Bernaldez M; Stamatis SD; Rose JP; Sun R
J Phys Chem B; 2024 Feb; 128(7):1668-1679. PubMed ID: 38232311
[TBL] [Abstract][Full Text] [Related]
3. Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.
Asano D; Takakusa H; Nakai D
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258058
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C
Twarog C; Fattal E; Noiray M; Illel B; Brayden DJ; Taverna M; Hillaireau H
Int J Pharm; 2022 Oct; 626():122131. PubMed ID: 36028084
[TBL] [Abstract][Full Text] [Related]
5. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
Kneiszl R; Hossain S; Larsson P
Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
[TBL] [Abstract][Full Text] [Related]
6. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
[TBL] [Abstract][Full Text] [Related]
7. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
8. The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.
Dahlgren D; Sjöblom M; Hedeland M; Lennernäs H
Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 31991924
[TBL] [Abstract][Full Text] [Related]
9. Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
Hossain S; Kneiszl R; Larsson P
Nanoscale; 2023 Dec; 15(47):19180-19195. PubMed ID: 37982184
[TBL] [Abstract][Full Text] [Related]
10. Formulation strategies to improve the efficacy of intestinal permeation enhancers
Maher S; Brayden DJ
Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
Kim JC; Park EJ; Na DH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]